Clinical Studies


Veloxis has a robust clinical trial program with completed and planned studies profiling immunosuppression therapies in transplantation.


cs1


Veloxis has conducted multinational studies involving 148 transplant centers in the US, and multiple centers outside of the US, including Canada, South America, Europe, and within the Asia-Pacific regions.


cs2


If you are interested in learning more about our completed studies or proposed studies contact Medical Information at medinfo@veloxis.com or +1 919 591 3090.